【摘 要】
：
Objective: To explore the efficacy of transarterial chemoembolization (TACE) for HCC patients with different portal vein tumor thrombosis (PVTT), to reveal which PVTT types could benefit from the trea
【机 构】
：
Department of Interventional Radiology,First Affiliated Hospital of Zhengzhou University
【出 处】
：
第十届中国介入放射学学术大会(CSIR2012)暨2012国际栓塞会议(GEST2012)
论文部分内容阅读
Objective: To explore the efficacy of transarterial chemoembolization (TACE) for HCC patients with different portal vein tumor thrombosis (PVTT), to reveal which PVTT types could benefit from the treatment.Methods: From October 2008 to December 2011, 101 HCC patients with PVTT were treated with TACEand clinical data was collected and analysis retrospectively.Survival analysis stratified by a new classification of PVTT were performed.
其他文献
目的:了解中国近年乳腺癌患者治疗现状,以推进国内乳腺癌规范化治疗的进行;评估卡培他滨联合化疗后续卡培他滨单药维持治疗的疗效和安全性.方法:共分析1680例一线或者二线使用卡培他滨联合化疗(XT/XP/XN/其他)的晚期乳腺癌患者,其中进入卡培他滨单药维持化疗的患者1235例.
Objective: Neoadjuvant chemotherapy draws more attention these years due to many theoretical advantages, of which better compliance is one, however, it hasnt been fully proved.We aimed to compare the
Objective: Gastric cancer is a common cancer with relatively poor survival rates.Gastric resection and intravenous chemotherapy are the current accepted standard treatment.Intraperitoneal chemotherapy
Objective: Gastric cancer is one of the most common malignant tumors in China and radical gastrectomy remains the only way to cure it.Total gastrectomy, as a frequently used operation in gastric cance
Objective: The new oral multi-kinase inhibitor REG improves overall survival (OS) in mCRC patients who progress after standard therapies.CONCUR (NCT01584830) evaluated the efficacy and safety of REG i
Objective: To compare the long-term survival of operated and non-operated colon cancer (CC) in young patients with elderly ones.Method: Using Surveillance, Epidemiology, and End Results (SEER) populat
目的:本研究拟通过三阴性乳腺癌有关的免疫标记物的表达、临床表现及生物学行为等一系列研究,探讨具有基底细胞样表型的三阴性乳腺癌的临床病理特征及预后相关因素.方法:收集128例1999年1月-2006年12月术前未接受任何治疗、无第二原发肿瘤的ER、PR、HER2阴性乳腺癌患者的临床病理资料,追踪随访患者生存信息,复阅切片,择取有代表性的肿瘤组织,应用组织微阵列技术、免疫组化染色技术,检测ER、PR、
Objective:To evaluate sorafenib (Sor) use in clinical practice in patients with hepatocellular carcinoma (HCC).Methods:GIDEON is a prospective, international, observational study.Patients with diagnos
Objective: The optimal time from surgery to the start of adjuvant chemotherapy in colon cancer is unknown.We evaluated the impact on survival of intraportal chemotherapy (IPC) administered during surg
Objective: The diversity of cancer genome significantly influences drug response and impairs the discovery of biomarker for patient stratification.As important preclinical models, patient derived cell